The monitoring of patent settlements (fourth report)
By Dr Wolfgang Rehmann and Diana Heimhalt
On 9 December 2013, the European Commission published its report on the monitoring of patent settlements concerning the period from January to December 2012. The intention of the European Commission is to continue the monitoring of patent settlements between originator and generic companies and to identify those settlements that delay generic market entry to the detriment of the European consumer, possibly in violation of European competition law.
According to the fourth monitoring exercise undertaken by the European Commission, 183 patent settlement agreements were concluded in the European Economic Area (EEA) between 1 January 2012 and 31 December 2012. Therefore, the present exercise has confirmed the increasing use of patent settlements in the European pharmaceutical sector. The results show that the commission’s announcement that it would continue scrutinising this kind of settlement in the future has not hindered companies from concluding settlements in general…
If you are registered and logged in to the site, click on the link below to read the Taylor Wessing briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
Why register to The Lawyer
More relevant to you
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
For the tax year from 6 April 2014, the standard lifetime allowance has reduced from £1.5m to £1.25m.
One of the areas highlighted last year by the Regulator was the regulation of workplace DC pension schemes.
Analysis from The Lawyer
As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014.
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world